Exploring threats to generalisability in a large international rehabilitation trial (AVERT).

Title : Exploring threats to generalisability in a large international rehabilitation trial (AVERT)

Source : PubMed
ID : 26283667
Authors : Bernhardt J, Raffelt A, Churilov L, Lindley RI, Speare S, Ancliffe J, Katijjahbe MA, Hameed S, Lennon S, McRae A, Tan D, Quiney J, Williamson HC, Collier J, Dewey HM, Donnan GA, Langhorne P, Thrift AG; AVERT Trialists’ Collaboration.
Year : 2015
Disease Category : Rehabilitation
Focused Population : Not Specified
Priori/Posteriori : Posteriori
Single-study Generalibility? : Single
Score/Non-Score : Non-score
Tutorial/Method : NHANES_T2D
Compared general demographic and patient characteristics : Yes
Compared disease-specific clinical characteristics : Yes
Compared adverse events : No
Compared outcomes/treatment effect (including survival) : No
Trial participants v.s. non-participants (excluded by the trial, or eligible but non-randomized) : Yes
Trial participants vs. general population (from EHR, survey, a cohort, etc) : Yes
Real-world data sources : VISTA databas (Virtual International Stroke Trials Archive)
Target Population Data Type Levels : International